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HIGHLIGHTS 
 Ibuprofen treatment seems not to have any negative influence on radiological outcomes of 
Colles’ fracture. 
 Ibuprofen treatment seems not to have any negative influence on functional outcomes of 
Colles’ fracture. 
 Ibuprofen treatment has the potential for opioid sparing effect for patients with the Colles’ 
fracture.  
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ABSTRACT 
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) may delay bone healing. This 
knowledge is mainly derived from retrospective uncontrolled clinical studies and from animal 
experiments. The purpose of this prospective controlled study was to investigate whether ibuprofen 
influences pain, function, and bone healing after a Colles’ fracture.                                                                                                                           
 
Patients and methods: A single center, triple-blind, randomized clinical trial. 95 patients, 80 females and 
15 males, with displaced Colles’ fracture aged median 65 (range 40-85) years old were included and 
operated by external fixation from June 2012 through June 2015. 89 participants received 
interventional medicine and 83 completed the one-year follow-up.  The 7-day ibuprofen group 
received 600mg of ibuprofen three times a day, the 3-day ibuprofen group received ibuprofen for 
three days and a placebo for the following four days, and finally, the placebo group received a 
placebo for seven days. All patients received paracetamol 1000 mg four times a day and 50 mg 
tramadol if needed.  The primary outcome were radiological changes in radius tilt, length, and 
inclination observed during and 6 weeks after the surgery. The analgesic outcome were 14 days 
experience of pain, and registered use of tramadol. The functional outcomes were the percentage 
differences in the motion between the injured and non-injured wrist, and the DASH score at 3 and 12 
months. All analyses were performed according to the intention to treat.                                                                                                                                                                                                       
 
Results: No clinically relevant difference was observed in the radiological migration between the 
treatment groups, 0.064P0.81. There was no difference in the pain score between the treatment 
groups, P=0.13. The use of tramadol was lower in the ibuprofen groups than in the placebo group, 
P=0.035. Ibuprofen treatment did not affect the range of motion, 0.148≤P≤0.963. Patients in all groups 
demonstrated DASH score, and wrist motion improvement, close to 90% of normal amplitude. The 
complication rate was higher in the 7-day ibuprofen group compared to the placebo group, P=0.043. 
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Conclusions: Ibuprofen treatment demonstrated a tramadol-sparing effect during the postoperative 
period. Neither wrist function nor radiological migration were influenced. The complication rate 
was higher in the ibuprofen-treated group compared the placebo-treated group. 
 
 
KEY WORDS: NSAIDs, ibuprofen, fracture healing, Colles’ fracture fragment migration, pain, wrist 
function.                                               
 
 
 
INTRODUCTION 
Background                                                                                                                                                                                                            
Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used analgesics. 
They are inflammation-reducing medications. Inflammation is also an essential part of the early stage 
of bone fracture healing. Mechanical damage to bone cell membranes releases arachidonic acid, 
which is converted by cyclooxygenase-2 into pain-mediating pro-inflammatory prostaglandins. 
Fracture hematoma occurs immediately after injury due to broken vessels, is characterized by 
hypoxia and low pH, and contains pro-inflammatory cytokines and cells [1]. Cyclooxygenase-2 
(COX-2) levels are increased in fracture hematomas and, besides having pro-inflammatory activity, 
are also able to promote angiogenesis and the differentiation of mesenchymal cells into osteoblasts 
[2]. 
Many animal studies show NSAIDs have an apparent tendency to delay bone healing [3] although 
the healing delay was not noticeable when NSAIDs were used for a short period of time of seven days 
[4]. There is still no consensus as to whether short-term NSAID treatment affects bone healing [5], 
[6]. 
A distal forearm hand fracture is a common injury with over 1.46 million new cases reported in 1998 
in the United States, accounting for 1.5% of all emergency department cases [7]. Many older patients 
sustain this fracture and may subsequently experience reduced function of the injured wrist, 
especially if there is secondary dislocation of the bone fragments [8]. 
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Rationale                                                                                                                                                                                                                               
The question is whether ibuprofen is an effective analgesic after Colles’ fracture, without hampering 
bone healing.  
PATIENTS AND METHODS 
Study design and consent                                                                                                                                                                                                          
Our study was a one-center, randomized, triple-blind, clinical trial in which patients with unstable 
Colles’ fracture were recruited for treatment with ibuprofen or placebo. The study complied with 
the principles of the Declaration of Helsinki [9], followed Good Clinical Practice requirements [10], 
and was approved by the Danish National Medicines Agency (Reg. No. ******), the ****** 
Regional Ethics Committee (Reg. No. **********), and the ***** Data Protection Agency (J. no. 
*********). The study was registered with the European Clinical Trials Database (EudraCT number 
***********) and on the clinicaltrials.gov database (**********). None of the sponsors of this 
study was involved in the design or conduct of the study, data analysis, or writing of the manuscript. 
The first author takes responsibility for the integrity and accuracy of the reported data and the 
fidelity of the study to the protocol. We followed the guidelines for reporting parallel group, 
randomized, controlled trials [11]. Independent monitors assessed the overall performance of the 
study. 
Participants/study subjects 
Patients with acute, unstable, Older type III–IV Colles’ fractures who needed surgical treatment 
were selected at *************. Other inclusion criteria was age between 40 and 85 years.  
Exclusions criteria were age 40 years or 85 years, systematic treatment with NSAIDs, previous 
fractures of the wrist in question, a lack of mental and physical capacity to follow the study 
instructions, medical contraindications to the use of NSAIDs, pregnancy, and postoperative 
dislocation of the fracture. 
                                                                                                                                                                                                                                                  
Description of study treatments                                                                                                                                                                                                                                                              
The study was a prospective, randomized, 1:1:1 controlled, triple-blind clinical trial and consisted of 
three treatment groups. The 7-day ibuprofen group was treated with 600 mg of ibuprofen three 
times daily for seven days. The 3-day ibuprofen group was treated with 600mg of ibuprofen three 
times daily for the first three days and then given a placebo three times daily for the remaining four 
days. The placebo group was treated with a placebo three times daily for seven days. The patients 
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did not receive prophylactic medication with proton pump inhibitors or other acid neutralizing 
agents. 
The Hospital Pharmaceutical Department performed block randomization 45 + 48 + 3.  The patient, 
the surgeon, the data manager, and the statistician were all blinded.   
Participants received a package of dosed analgesics, each of which included 1 g of paracetamol, four 
times a day for seven days, six 50 mg tablets of tramadol for use at the patient’s request, and the 
specified doses of ibuprofen or placebo.                                                                                                                                                                                 
External fixation bridging using K-wires and a Hoffman II external fixator (Stryker®) was preferred 
as the standard method of surgery in this study. This operation can be used to treat unstable 
fractures [12] and remains a viable method of treatment [13]. The same surgeon performed all 
surgeries in this study to standardize the treatment as best as possible. All patients received an infra-
clavicular regional nerve block, either with or without general anesthesia.  
For logistical reasons as a result of reduced capacity of the operating department, it was not possible 
to operate on patients at the same time after injury. The median operation time was two days post 
injury, with an overall range of 1 – 3 days post injury. 
Description of follow-up routine                                                                                                                                                                                
All patients were invited to outpatient clinic for  
 one weeks’ control (radiological assessment)  
 two weeks control (radiological assessment, collection of pain diary)  
 six weeks’ control (radiological assessment, removal of external fixation, measurement of 
range of motion in both wrists)  
 three months’ control (range of the motion, evaluation of the DASH score) 
 one-year control (range of the motion, evaluation of the DASH score). 
Outcome measures                                                                                                                                                                                                                       
The primary outcome were the radiological migration of bone fragments. The degree of displacement 
with regard to radius tilt, length, and inclination was determined using the EasyViz diagnostic 
program (Karos Health Incorporated), and calculated as the difference between the result 
immediately after surgery and the result at six weeks post-operatively. The fractured bone fragments 
were expected to migrate from the best position immediately after surgery toward a worse position 
[14, 15, 16].  Three radiological measurements were evaluated. The distal radius inclination: the angle 
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between the radius’ joint surfaces (the ulnar corner and the tip of the radius styloid in the 
anteroposterior projection). The dorsal tilt of the radius’ distal fragment: the angle between the 
longitudinal radius’ axis and the radius’ joint surface in the lateral projection. The distal radius 
length between the ulnar joint surface and the tip of the radius styloid in the anteroposterior 
projection.                                                                                                                                                                              
An image intensifier was used during the operations and its pictures saved for documentation and 
analysis. Length in those pictures was measured in pixels, whereas, standard X-ray pictures from 
controls used mm as the unit of measurement. A standard 1.4 mm K-wire was used as a calibration 
device on perioperative pictures to measure thickness in pixels and to calculate an individual pixel 
value in millimeters, using the formula: pixel value = 
1.4 𝑚𝑚
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑒𝑑𝑔𝑒𝑠 𝑜𝑓 𝐾−𝑤𝑖𝑟𝑒
 . 
The evaluation of ibuprofen’s analgesic effect using the daily pain score, measured with the Likert 10-
point scale [17], one point for “no pain” and ten for “unbearable pain.” The patients were asked to 
register their pain from inclusion in the study and three times a day for the following 14 days, and to 
record the use of tramadol. The mean pain score for each of the three groups during the period of 1 – 
3 days, 4 – 7 days, and 8 – 14 days was calculated.  
As the functional outcomes, we evaluated the analgesic effect of ibuprofen, wrist range of motion, 
and the DASH score [18].   
We measured the motion of the wrist from the neutral position in extension and flexion; supination 
and pronation; and radial and ulnar deviation. The range of motion was measured at six weeks, three 
months, and one-year follow-up, and percentage difference in the range of motion between injured 
and non-injured wrist was calculated.  
The DASH survey contained 30 questions with a focus on standard circumstances in everyday life. 
Each inquiry had a five-point scale, with one point scored for the best function, and five points for 
the worst. DASH surveys with three or more unanswered inquiries were excluded from the data 
analysis. The estimation of the DASH result was computed by use of the formula: [((sum of points 
from n responses)/n) - 1] x 25, where n was the number of questions answered by the patient.  
                                                                                                                                                                                     
Missing data were multiply inputted in the primary analysis by an independent blinded statistician 
to increase the precision of the estimates and to avoid potential biases. 
 
Statistical analysis, study size                                                                                                                                                                                                    
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A detailed statistical analysis plan was made publicly available before the follow-up was completed 
and the analyses were performed [19]. The sample size calculation was based on changes in radius 
tilt to test the null hypothesis that NSAID treatment was not inferior to the placebo. The calculation 
was based on a one SD=9.4o incidence of dorsal tilt [20] and 8o as the limit of reliable measurement 
[21]. The power was defined to 90%. Therefore, to attain a 90% probability of rejecting null 
hypothesis using a one-sided 0.05 level test, 66 participants (three equal groups of 22 patients) were 
required.                                                                                                                                                                                                                                           
To allow for a combined 20% dropout rate and loss to follow-up, and to approximate the normal 
distribution, 96 participants were recruited in total being three groups with 32 patients in each. 
Frequency histograms and Q–Q plots were used to check whether the data from each sample were 
normally distributed or not. In cases where the data were normally distributed and there was 
homoscedasticity in all samples, Student’s t-tests with a Dunn–Šidák correction (α = 1 – (1 – 0.05)1/k, 
where k is the number of tests, performed) were used to detect significant differences between mean 
group changes for all outcomes. If the data were not normally distributed, the Kruskal–Wallis 
nonparametric significance test was used. 
Additionally, a Z-test was performed to compare the proportions of side effects and complications 
between the treatment groups.  
 
MATERIALS 
A total of 280 patients were screened between 1 June 2012 and 20 June 2015 (Figure 1, Table 1). Of 
these patients, 95 were included (an enrolment rate of 33.8%), 121 (43%) were not asked to 
participate due to time shortages in the emergency department, 45 (16%) were not interested in 
participating, and 19 (6.8%) fulfilled the exclusion criteria. One pack containing study medication 
was given to a patient with another type of fracture. 
The majority (n=80) of included patients were women, and the median age was 65 years (range: 
42−85 years). 89 of the included patients received the allocated treatment while the remaining six 
patients did not (regret, noncompliance). Four patients retracted their acceptance to participate, 
three patients lost their pain diary, one patient suffered side effects from the treatment (nausea) and 
left the study, one patient died before the 1-year follow-up, and one patient was operated on in a 
different way to that predefined in this study and was subsequently excluded with a secondary 
dislocation. One patient was excluded from the radiological evaluation due to insufficient quality of 
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the X-ray pictures. 85 patients, divided into three groups, were analyzed according to the intention 
to treat. 
 
RESULTS 
Radiological outcomes                                                                                                                                                                                                             
The changes in radius tilt, length, and inclination followed the same trend in all groups. There were 
no clinically relevant or statistically significant differences (0.064  P  0.81) in radiological 
migration between the treatment groups (Figure 2).  
 
Pain outcomes                                                      
There was no statistically significant difference in the mean pain score between the treatment 
groups at any time of follow-up, χ2=3.95, P=0.13. (Figure 3). 
Tramadol use was highest in the placebo group with the peak difference at day 2 (Figure 4). During 
the first 3 days, the median of tramadol consumption was 2 (0-7) tablets in the placebo group and 1 
(0-9) tablet in the ibuprofen groups (χ2=4.43, P=0.035).  
 
Functional outcomes                                                                                                                                                                                                                                                                               
Patients in all treatment groups demonstrated the same pattern of wrist joint motion improvement 
during the follow-up period, which corresponded to 87%–95% of the normal range of movement at 
the 1-year follow-up (Figure 5). No statistically significant differences were observed between the 
treatment groups at any of the follow-up checks (P=0.148–0.963, Table 5.7). 
The placebo group achieved a higher mean DASH score of 19.95 (SD=14.18) than the 3-day (mean 
DASH score=17.87, SD=14.47) and 7-day groups (mean DASH score=15.07, SD=10.77). The mean DASH 
scores in treatment groups were not significantly different (χ2=1.48, P=0.47, (Figure 6)).                         
Complications and adverse events                                                                                                                                                                                      
The most common complication was a gastrointestinal disorder, which was observed in four 
patients in the placebo group, seven patients in the 3-day group, and eight patients in the 7-day 
group (Table 2). The number of adverse events in the 7-day ibuprofen and placebo groups were 
significantly different (Z=1.709, P=0.043). We observed no severe treatment-related complications in 
any of the groups.   
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DISCUSSION                                                                                                                                                                      
Although bridging external fixation with additional pinning of Colles’ fracture fragments is 
recognized as a reliable method of osteosynthesis [22], the stability is not rigid and fragments will 
migrate even six weeks post-operatively [23]. A systematic search in PubMed and Embase identified 
two studies [24, 25] that describe the radiological migration of Colles’ fractures in relation to NSAID 
treatment. Both of these studies treated their patients conservatively, and therefore the results 
cannot be compared with the radiological outcomes of this study.  
The results from this study are comparable with other studies that described radiological outcomes 
after bridging external fixation of the distal radius. In a randomized prospective study comparing 
different types of osteosynthesis six weeks after external fixation, Wei et al. [20] found a similar 
radial inclination, volar tilt, and radial length in the external fixation group. Wright et al. [26] 
compared radiological outcomes in their retrospective study of volar plating and external fixation 
and found a radial inclination and a volar tilt at 47 months follow-up, comparable to our results. 
Our study shows the same pattern of fragment migration in all treatment groups and no statistically 
significant difference was found in the extent of the secondary displacement. Average inclination, 
tilt, and length of the distal radius in all treatment groups was comparable to normal anatomical 
form, which is essential for long-term wrist function as described by Dario [27]. 
 
This study showed no significant differences in the pain experienced between the groups treated 
with ibuprofen or the placebo group. All patients received sufficient pain treatment with 
paracetamol as the primary treatment, with or without ibuprofen as a supplement, and tramadol as 
an escape medicine. The 3-day ibuprofen group reported increased pain from day 3 to day 4, which 
corresponded to the time when ibuprofen was replaced with the placebo, and pain remained higher 
in this group during the 14-day follow-up period. 
Tramadol use during the first three days was significantly higher in the placebo group compared to 
the ibuprofen treatment groups. Our results suggest treatment with ibuprofen in the acute phase 
may be beneficial and have an opioid-reducing effect, as it is demonstrated by other studies[28]. 
Patients with shorter-term or no ibuprofen treatment requested more tramadol to maintain their 
pain at the same acceptable level as patients treated with ibuprofen for seven days.  
Davis et al. [25] treated Colles’ fracture patients in a prospective randomized, double-blind study 
using flurbiprofen for 14 days. The authors found significant pain relief and a paracetamol-sparing 
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effect during the first three days but reported results in categorical units. The varying doses of 
NSAIDs in the intervention group and a mean age difference of 8.4 years between the treatment 
groups makes the interpretation of their results difficult. 
Adolphson et al. [24] performed a prospective randomized, double-blind study with two treatment 
groups containing 21 postmenopausal women with Colles’ fractures in each. One group was treated 
with piroxicam and the other was treated with placebo, for eight weeks. Paracetamol was given as a 
rescue medicine. Pain level was assessed with a 10-point visual analog scale and was found to be 2.1 
in the piroxicam group and 3.1 in the placebo group at ten days. Consumption of rescue medication 
was significantly less in the piroxicam group. This study included a small sample size of severe, 
comminuted, unstable fractures scheduled for conservative treatment where 14% of the patients 
subsequently were surgically treated with external fixation. The severity of the fracture and the 
treatment method may be confounding factors in pain experience and functional outcomes. 
Lee et al. [29] performed a prospective, randomized study regarding the effect of transcutaneous 
electric nerve stimulation (TENS) on acute pain after Colles’ fracture. The authors found the mean 
pain VAS score reduced from 5.5 points on day 1 to 3.5 points on day 4 in subjects that received the 
TENS treatment. All patients were treated with NSAIDs and were operated on using volar plating. 
In our study, patients reported less pain during the first days, likely due to the minor surgical 
intervention. The pain experienced later in Lee’s study was comparable to our results. 
In our study, wrist joint mobility improved equally in all treatment groups during the first year after 
injury. A previous prospective study by Davis et al.[25] described the influence of NSAIDs on 
functional outcomes after Colles’ fracture and demonstrated no differences in one-year functional 
outcomes of displaced fracture, after two weeks of treatment with flurbiprofen. The patients used on 
demand medication for 14 days (three to six trials tablets daily). The inconsistent dose of NSAIDs in 
the intervention group and mean age difference of 8.4 years between intervention and placebo 
groups makes the interpretation difficult.                                                     
A prospective, randomized double-blind and placebo-controlled study by Adolphson demonstrated 
a similar result. [24] There were no differences in functional outcomes at three months follow-up. 
The intervention group received piroxicam for eight weeks. A small sample size, coupled with severe 
comminuted Colles’ fractures scheduled for conservative treatment and thus subsequent operation, 
of 14% of the study population, may influence the validity of this trial.  
Wright et al.[26] compared functional outcomes in a retrospective study after volar plating and 
external fixation of Colles’ fracture and reported similar DASH results in the external fixation group 
at 47-months follow-up.  
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Kamath et al.[30] showed in a cohort study that the mean DASH score and wrist range of motion at 
18-months follow-up results were comparable to our study. Aktekin et al.[31], in their retrospective 
study, described the same DASH results at two-year follow-up. The patients in our study 
demonstrated DASH scores comparable to patients treated with volar plating in a study by Richard 
[32]. 
Treatment with ibuprofen did not demonstrate significant changes in DASH score between 
treatment groups. On the other hand, ibuprofen seems to may have a dose-dependent improving 
influence on both 3-month and 1-year DASH outcome. The mechanism still needs clarification but 
may be explained by edema reduction [33] and tendon adhesions preventing the effects [34].  
A study with extended ibuprofen treatment (several weeks or even months) may be more powerful 
in demonstrating the true influence on functional outcomes.  
 
Prolonged treatment with NSAIDs is related to an increased risk of cardiovascular, gastrointestinal, 
and nephrological disorders [35]. From a clinical perspective, a lengthy treatment is not necessary for 
the acute period and the following osteosynthesis of Colles’ fracture. 
The rate of complications and side effects was significantly higher in the 7-day ibuprofen group 
compared to the placebo group and gastrointestinal disorders were observed in all three treatment 
groups. A few patients may have experienced digestive symptoms due to other factors (e.g., stress 
during the first days after injury or surgery) and this has to be taken into account when determining 
whether the adverse effects are ibuprofen-related or not. The incidence rates for gastrointestinal 
disorders in the 3- and 7-day groups were 23.3% and 27.6%, respectively. These rates were higher 
than in other studies reporting oral treatment with NSAIDs [36]. We did not use prophylactic 
medication with proton pump inhibitors or other acid neutralizing agents. Given this, the number of 
side effects attributable to the NSAID use may probably be less.               
 
Our study has several limitations. There are only a few randomized clinical trials regarding NSAID 
treatment of fracture patients. Patients sustained the fracture at different times of the day, some 
received analgesics on the morning of day one while others had no fracture and no pain until the 
evening of day one. This may lead to some uncertainty regarding the first day’s pain experience and 
some variability at the moment when the patient took their last ibuprofen or placebo tablet after the 
injury. Attempts were made to include all patients during their first visit to the emergency 
department; however, it was not possible to assure that all patients took the medicine at the same 
time after the injury.  
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Some patients also waited a day or more hoping that they only had a sprain or contusion and 
therefore came to the emergency department on the second or third day. Others were not asked to 
participate in the study because staff were too busy, and this job was left to the researcher to do 1–2 
days later. These logistical reasons meant that it was not possible to assure that ibuprofen was given 
at the same time point of the fracture inflammation phase.  
Shortages in the operation department’s capacity also meant that it was not possible to operate on 
the patients at the same time after injury. This caused that pain symptoms were relieved by regional 
anesthesia at different periods during the first 3 days, which may explain some irregularities in pain 
dynamics in the patient’s diaries. This limitation is in some degree compensated by equal 
distribution of the treatment and operation time in our study groups. 
Another potential limitation was the lack of exact standardization using X-ray pictures and lateral 
projections, as these may vary by a few grades in rotation and may influence the subsequent tilt 
assessment. There was also uncertainty in measuring the radius length in the perioperative pictures  
due to the blurred contours of the K-wire, zoomed digitally. 
The part of the study describing the functional and radiological outcomes had a non-inferiority 
design. The limitation of the non-inferiority design is whether there was a proper sample size. 
Treatment groups demonstrated a difference in the range of motion and DASH scores that were less 
than 30% of the SD within groups and differences in radiological migration that were less than 50% 
of the SD within groups. With an  significance level of 0.05 (according to recommendations for 
non-inferiority trials [37]), the sample size in this study was considered to have proper strength. 
 
CONCLUSIONS 
The treatment with ibuprofen had an opioid-sparing effect and did not demonstrate any harmful 
influence on a patient’s radiological and functional outcomes. These findings may offer support as an 
indication for ibuprofen treatment in the acute fracture phase; however, the risks of ibuprofen’s side 
effects need to be considered. 
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Assessed for eligibility from June 01, 
2012 until June 20, 2015 (N=280) 
Randomized (N=95) 
Not included (N=185) 
   Not asked (N=121) 
   Declined to participate (N=45) 
   Did not meet inclusion criteria 
(N=19) 
Allocated to intervention 
placebo group (N=32) 
 Received allocated 
intervention (N=30) 
 Did not receive allocated 
intervention (regret, N=2) 
 
Allocated to intervention 3-
day ibuprofen group (N=32) 
 Received allocated 
intervention (N=30) 
 Did not receive allocated 
intervention (no 
compliance, N=2) 
Allocated to intervention 7-day 
ibuprofen group (N=31) 
 Received allocated intervention 
(N=39) 
 Did not receive allocated 
intervention (1–regret, 1–no 
compliance, N=2) 
Allocation 
Enrollment 
2 patients lost at 1 years follow-
up (regret)                         
2 patients lost at 6 weeks 
follow-up (regret)                                      
1 patient lost at 1 years control 
(death), 1 patient discontinued 
intervention (side effects)               
       
Follow-Up 
Analyzed:                                
Pain in 14 days (N=29), 1 
excluded from analysis (lost 
pain diary)                          
Radiological migration (N=30)                          
Range of wrist motion (N=29)      
DASH score (N=28), 1 patient 
excluded due  to more than 3 
questions, not answered       
                             
Analyzed:                                      
Pain in 14 days (N=28), 2 
excluded from analysis (lost pain 
diary)                        
Radiological migration (N=30)   
Range of wrist motion (N=28)                                    
DASH score (N=27), 1 
excluded due to contralateral 
wrist fracture         
                             
Analyzed:                                 
Pain in 14 days (N=28)                   
Radiological migration 
(N=28), 1 excluded from 
analysis due to improper 
picture quality            
Range of wrist motion 
(N=27)                            
DASH score (N=27) 
      
Analysis 
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Figure 2. Radiological fragment migration in treatment groups (with 95% CI) 
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Figure 3. Pain dynamics in treatment groups (with 95% CI) 
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Figure 4. Tramadol use on request (with 95% CI) 
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Figure 5. Changes in range of movement in the injured wrist joint (with 95% CI) 
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Figure 6. Changes in the DASH score in treatment groups (with 95% CI) 
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Table 1. Baseline characteristics of the study patients 
 
Table 1. Baseline characteristics of the study patients 
Group 
Total 
analyzed 
Female\Male 
Average age 
(years) 
Dominating\Not  
Placebo group 30 25\5 64.3 ± 4.4 15\15 
3-day ibuprofen group 30 25\5 67,8 ± 10 13\17 
7-day ibuprofen group 29 24\5 65,4 ± 7.9 14\15 
 
 
 
 
Table 2. Adverse events  
Table 2. Adverse events *comparison of the placebo group and the 7-day group 
  
Placebo 
group 
3-day 
group 
7-day 
group 
Statistics 
Overall 10 of 30 12 of 30 16 of 29 
Z* = 1.709, P = 
0.043 
Gastrointestinal disorders 4 7 8   
Nerve numbness 6 2 5   
Pinholes infection 0 1 2   
Loosening of osteosynthesis 
material 
0 2 0 
  
Serious secondary dislocation 0 0 1   
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